# Gordian Ventures

Gordian Ventures is a Venture Capital based in Shanghai, China.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** https://gordian.com
- **LinkedIn:** https://www.linkedin.com/company/gordianvc

## Regulatory record

- **Reports private funds:** No

## About

Gordian Ventures is a venture capital firm that has made one investment, deploying $77 million in total capital. Its primary sector focus is biotechnology.

## Sectors

- Life Sciences
- Biotechnology
- Pharmaceuticals

## Offices

- Boston, MA, United States
- Cambridge, MA, United States

## Questions

### How does Gordian Ventures source its pipeline of therapeutic programs?

Gordian Ventures primarily sources intellectual property through relationships with academic research institutions, particularly in the Greater Boston area, including known ties to laboratories at MIT and Harvard. The firm evaluates early-stage biomedical research and identifies programs with translational potential, then builds dedicated companies to advance those assets. This is a venture-creation model rather than a traditional deal-screening fund model.

### What does Gordian’s operational presence in both the US and China enable?

The firm’s footprint across Boston, Cambridge, and Shanghai allows it to bridge US-based academic innovation with China-based capital formation and development capabilities. Life-science companies formed by Gordian can access research talent and institutional scientific infrastructure in the United States while navigating clinical development, manufacturing partnerships, and Asian capital markets from a Chinese operating base.

### What therapeutic areas does Gordian Ventures focus on?

The firm concentrates on early-stage biotechnology and pharmaceutical programs, with an emphasis on novel drug-discovery platforms and therapeutic assets. Sectors of activity include small-molecule drug development, biologics, and platform technologies that emerge from translational academic research. Public records do not identify specific clinical-stage programs or approved products.

## Related profiles

- [Addus HomeCare](https://altss.com/profile/addus-homecare)
- [Solenis](https://altss.com/profile/solenis-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/gordian-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology